Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001782675 | SCV002024730 | likely pathogenic | not provided | 2019-12-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002541209 | SCV003250911 | pathogenic | Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | 2023-09-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln609*) in the POR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POR are known to be pathogenic (PMID: 14758361, 20732302, 21741353). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1324955). This premature translational stop signal has been observed in individual(s) with clinical features of cytochrome P450 oxidoreductase deficiency (PMID: 32242900). This variant is present in population databases (rs782261248, gnomAD 0.003%). |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV003136154 | SCV003806734 | pathogenic | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis | 2023-01-12 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PM2 moderated, PP1 supporting |
Gene |
RCV001782675 | SCV003842544 | pathogenic | not provided | 2023-03-20 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 29754767, 32242900) |
Fulgent Genetics, |
RCV005040379 | SCV005667479 | likely pathogenic | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis; Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency | 2024-01-15 | criteria provided, single submitter | clinical testing |